UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Cellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy

Phang, Ren Jie; Ritchie, Rebecca H; Hausenloy, Derek J; Lees, Jarmon G; Lim, Shiang Y; (2022) Cellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy. Cardiovascular Research 10.1093/cvr/cvac049. (In press). Green open access

[thumbnail of Hausenloy_cvac049.pdf]
Preview
Text
Hausenloy_cvac049.pdf

Download (1MB) | Preview

Abstract

Patients with Type 2 diabetes mellitus (T2DM) frequently exhibit a distinctive cardiac phenotype known as diabetic cardiomyopathy. Cardiac complications associated with T2DM include cardiac inflammation, hypertrophy, fibrosis and diastolic dysfunction in the early stages of the disease, which can progress to systolic dysfunction and heart failure. Effective therapeutic options for diabetic cardiomyopathy are limited and often have conflicting results. The lack of effective treatments for diabetic cardiomyopathy is due in part, to our poor understanding of the disease development and progression, as well as a lack of robust and valid preclinical human models that can accurately recapitulate the pathophysiology of the human heart. In addition to cardiomyocytes, the heart contains a heterogeneous population of non-myocytes including fibroblasts, vascular cells, autonomic neurons and immune cells. These cardiac non-myocytes play important roles in cardiac homeostasis and disease, yet the effect of hyperglycaemia and hyperlipidaemia on these cell types are often overlooked in preclinical models of diabetic cardiomyopathy. The advent of human induced pluripotent stem cells provides a new paradigm in which to model diabetic cardiomyopathy as they can be differentiated into all cell types in the human heart. This review will discuss the roles of cardiac non-myocytes and their dynamic intercellular interactions in the pathogenesis of diabetic cardiomyopathy. We will also discuss the use of sodium-glucose cotransporter 2 inhibitors as a therapy for diabetic cardiomyopathy and their known impacts on non-myocytes. These developments will no doubt facilitate the discovery of novel treatment targets for preventing the onset and progression of diabetic cardiomyopathy.

Type: Article
Title: Cellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1093/cvr/cvac049
Publisher version: https://doi.org/10.1093/cvr/cvac049
Language: English
Additional information: Copyright © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: Diabetic cardiomyopathy, autonomic neurons, cardiac fibroblasts, cardiomyocytes, endothelial cells, immune cells
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Pre-clinical and Fundamental Science
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
URI: https://discovery.ucl.ac.uk/id/eprint/10147161
Downloads since deposit
21Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item